Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
9,051,029
-
Share change
-
+9,051,029
-
Total reported value
-
$107,615,000
-
Price per share
-
$11.89
-
Number of holders
-
28
-
Value change
-
+$107,615,173
-
Number of buys
-
28
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q3 2020
As of 30 Sep 2020,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,051,029 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Johnson & Johnson Innovation - JJDC, Inc., Nantahala Capital Management, LLC, Ikarian Capital, LLC, BAILLIE GIFFORD & CO, BlackRock Inc., Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, and DAFNA Capital Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.